iA Global Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-351
Closed -$36K 420
2025
Q4
$36K Sell
351
-85,648
-100% -$6.88M ﹤0.01% 385
2025
Q3
$4.71M Buy
85,999
+7,500
+10% +$375K 0.06% 185
2025
Q2
$4.17M Sell
78,499
-1,689
-2% -$85.8K 0.06% 185
2025
Q1
$3.47M Buy
80,188
+7,436
+10% +$377K 0.06% 189
2024
Q4
$4.09M Buy
72,752
+3,110
+4% +$194K 0.07% 179
2024
Q3
$4.74M Buy
69,642
+3,060
+5% +$173K 0.08% 161
2024
Q2
$2.81M Buy
66,582
+25,762
+63% +$1.42M 0.05% 203
2024
Q1
$2.82M Buy
+40,820
New +$2.58M 0.06% 207
2023
Q4
Sell
-1,450
Closed -$99K 476
2023
Q3
$99K Sell
1,450
-639
-31% -$54.2K ﹤0.01% 456
2023
Q2
$196K Buy
+2,089
New +$163K 0.01% 422

Other funds holding EXAS

iA Global Asset Management's EXAS Position: Q1 2026 in Review

iA Global Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 351 shares — an estimated $36K sold.

iA Global Asset Management first reported a position in EXAS in Q2 2023 and held it in 10 quarters. The position peaked at $4.74M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • iA Global Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • iA Global Asset Management sold 351 Exact Sciences shares in Q1 2026, an estimated $36K.
  • iA Global Asset Management first reported a position in Exact Sciences in Q2 2023 and held it in 10 quarters.
  • iA Global Asset Management's Exact Sciences position peaked at $4.74M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.